Rosell R - Search Results

1

Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are going.

Rosell R, Cuello M, Cecere F, Santarpia M, Reguart N, Felip E, Taron M. Rosell R, et al. Curr Opin Oncol. 2006 Mar;18(2):135-43. doi: 10.1097/01.cco.0000208786.91947.eb. Curr Opin Oncol. 2006. PMID: 16462182 Review.

2

Phase I study of mitonafide in 120 hour continuous infusion in non-small cell lung cancer.

Rosell R, Carles J, Abad A, Ribelles N, Barnadas A, Benavides A, Martin M. Rosell R, et al. Invest New Drugs. 1992 Aug;10(3):171-5. doi: 10.1007/BF00877242. Invest New Drugs. 1992. PMID: 1330970 Clinical Trial.

3

A phase II study of days 1 and 8 cisplatin and recombinant alpha-2B interferon in advanced non-small cell lung cancer.

Rosell R, Carles J, Ariza A, Moreno I, Ribelles N, Solano V, Pellicer I, Barnadas A, Abad A. Rosell R, et al. Cancer. 1991 May 15;67(10):2448-53. doi: 10.1002/1097-0142(19910515)67:10<2448::aid-cncr2820671009>3.0.co;2-2. Cancer. 1991. PMID: 1707745 Clinical Trial.

4

Cyclophosphamide and ifosfamide combination as neoadjuvant chemotherapy for locally advanced nonsmall-cell lung cancer: a meta-analytic review.

Rosell R, Moreno I, Maestre J, Olazabal A, Carles J, Barnadas A, Abad-Esteve A, Ribelles N, Canela M. Rosell R, et al. J Surg Oncol. 1990 Oct;45(2):124-30. doi: 10.1002/jso.2930450213. J Surg Oncol. 1990. PMID: 2170771

5

Quality of life during chemotherapy in non-small cell lung cancer patients.

Fernandez C, Rosell R, Abad-Esteve A, Monras P, Moreno I, Serichol M, Roviralta M. Fernandez C, et al. Among authors: rosell r. Acta Oncol. 1989;28(1):29-33. doi: 10.3109/02841868909111177. Acta Oncol. 1989. PMID: 2539845

6

Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.

Carles J, Rosell R, Ariza A, Pellicer I, Sanchez JJ, Fernandez-Vasalo G, Abad A, Barnadas A. Carles J, et al. Among authors: rosell r. Lung Cancer. 1993 Dec;10(3-4):209-19. doi: 10.1016/0169-5002(93)90181-v. Lung Cancer. 1993. PMID: 7521264

7

Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancer.

Rosell R, Molina F, Moreno I, Martínez E, Pifarré A, Font A, Li S, Skacel Z, Gómez-Codina J, Camps C, et al. Rosell R, et al. Lung Cancer. 1995 Apr;12 Suppl 1:S59-70. doi: 10.1016/0169-5002(95)00421-v. Lung Cancer. 1995. PMID: 7551935 Clinical Trial.

8

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

Rosell R, Gómez-Codina J, Camps C, Maestre J, Padille J, Cantó A, Mate JL, Li S, Roig J, Olazábal A, et al. Rosell R, et al. N Engl J Med. 1994 Jan 20;330(3):153-8. doi: 10.1056/NEJM199401203300301. N Engl J Med. 1994. PMID: 8043059 Free article. Clinical Trial.

9

K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma.

Li S, Rosell R, Urban A, Font A, Ariza A, Armengol P, Abad A, Navas JJ, Monzo M. Li S, et al. Among authors: rosell r. Lung Cancer. 1994 Jul;11(1-2):19-27. doi: 10.1016/0169-5002(94)90279-8. Lung Cancer. 1994. PMID: 8081702

10

Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate.

Rosell R, Gómez-Codina J, Anton A, Sánchez JJ, Vadell C. Rosell R, et al. Semin Oncol. 1994 Feb;21(1 Suppl 1):48-53. Semin Oncol. 1994. PMID: 8153657 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

839 results

Search Page

Filters